1 |
Zhou J, Zhou F, Wang W, et al. Epidemiological features of NAFLD from 1999 to 2018 in China [J]. Hepatology, 2020, 71(5): 1851-1864.
|
2 |
邵幼林, 范建高. 非酒精性脂肪性肝病的流行现状与危害[J]. 中华肝脏病杂志, 2019, 27(1): 10-13.
|
3 |
Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease [J]. Gastroenterology, 2002, 123(3): 745-750.
|
4 |
Fujiwara Y, Kuroda H, Abe T, et al. The B-mode image-guided ultrasound attenuation parameter accurately detects hepatic steatosis in chronic liver disease [J]. Ultrasound Med Biol, 2018, 44(11): 2223-2232.
|
5 |
Kang KA, Lee SR, Jun DW, et al. Diagnostic performance of a novel ultrasound-based quantitative method to assess liver steatosis in histologically identified nonalcoholic fatty liver disease [J]. Med Ultrason, 2023, 25(1): 7-13.
|
6 |
Imajo K, Toyoda H, Yasuda S, et al. Utility of ultrasound-guided attenuation parameter for grading steatosis with reference to MRI-PDFF in a large cohort [J]. Clin Gastroenterol Hepatol, 2022, 20(11): 2533-2541.e2537.
|
7 |
中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南 [J/CD]. 中国肝脏病杂志(电子版), 2010, 2(4): 43-48.
|
8 |
Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation [J]. Am J Gastroenterol, 2007, 102(12): 2708-2715.
|
9 |
Xu C, Weng Z, Zhang L, et al. HDL cholesterol: A potential mediator of the association between urinary cadmium concentration and cardiovascular disease risk [J]. Ecotoxicol Environ Saf, 2021, 208: 111433.
|
10 |
Rinella ME. Nonalcoholic fatty liver disease: a systematic review [J]. JAMA, 2015, 313(22): 2263-2273.
|
11 |
张记, 闫艳, 李金燕. 超声声衰减成像对不同程度非酒精性脂肪肝的诊断价值 [J]. 临床超声医学杂志, 2023, 25(9): 718-722.
|
12 |
de Lédinghen V, Wong GL, Vergniol J, et al. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease [J]. J Gastroenterol Hepatol, 2016, 31(4): 848-855.
|
13 |
Chan WK, Nik Mustapha NR, Mahadeva S. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease [J]. J Gastroenterol Hepatol, 2014, 29(7): 1470-1476.
|
14 |
沈峰, 范建高. 瞬时弹性成像技术在脂肪性肝病中的应用现状 [J]. 中华肝脏病杂志, 2014, 22(9): 643-646.
|
15 |
Zhao Y, Jia M, Zhang C, et al. Reproducibility of ultrasound-guided attenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis [J]. Sci Rep, 2022, 12(1): 2876.
|
16 |
Kuroda H, Abe T, Fujiwara Y, et al. Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease [J]. J Med Ultrason (2001), 2021, 48(4): 471-480.
|
17 |
邢敏, 杨自力. 血脂、血糖、肝功能等生化指标联合超声诊断脂肪肝及评估其预后的价值 [J]. 肝脏, 2016, 21(4): 327-328.
|
18 |
吴成忠, 陈磊, 张丽. 超声诊断脂肪肝与血脂水平及肝功能的相关性评价 [J]. 影像研究与医学应用, 2020, 4(14): 185-186.
|
19 |
North BJ, Sinclair DA. The intersection between aging and cardiovascular disease [J]. Circ Res, 2012, 110(8): 1097-1108.
|
20 |
Yang Y, Song L, Wang L, et al. Effect of body mass index trajectory on lifetime risk of cardiovascular disease in a Chinese population: A cohort study [J]. Nutr Metab Cardiovasc Dis, 2023, 33(3): 523-531.
|
21 |
Kim Y, Han E, Lee JS, et al. Cardiovascular risk is elevated in lean subjects with nonalcoholic fatty liver disease [J]. Gut Liver, 2022, 16(2): 290-299.
|
22 |
Stefan N. Causes, consequences, and treatment of metabolically unhealthy fat distribution [J]. Lancet Diabetes Endocrinol, 2020, 8(7): 616-627.
|